HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification

Summary: The recent HIV-1 vaccine failures highlight the need to better understand virus-host interactions. One key question is why CD8+ T cell responses to two HIV-Gag regions are uniquely associated with delayed disease progression only in patients expressing a few rare HLA class I variants when t...

Full description

Bibliographic Details
Main Authors: Stefan Tenzer, Hayley Crawford, Phillip Pymm, Robert Gifford, Vattipally B. Sreenu, Mirjana Weimershaus, Tulio de Oliveira, Anne Burgevin, Jan Gerstoft, Nadja Akkad, Daniel Lunn, Lars Fugger, John Bell, Hansjörg Schild, Peter van Endert, Astrid K.N. Iversen
Format: Article
Language:English
Published: Elsevier 2014-04-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124714002095
id doaj-70c00bdc9a134a478cc0c679e6af3abb
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Stefan Tenzer
Hayley Crawford
Phillip Pymm
Robert Gifford
Vattipally B. Sreenu
Mirjana Weimershaus
Tulio de Oliveira
Anne Burgevin
Jan Gerstoft
Nadja Akkad
Daniel Lunn
Lars Fugger
John Bell
Hansjörg Schild
Peter van Endert
Astrid K.N. Iversen
spellingShingle Stefan Tenzer
Hayley Crawford
Phillip Pymm
Robert Gifford
Vattipally B. Sreenu
Mirjana Weimershaus
Tulio de Oliveira
Anne Burgevin
Jan Gerstoft
Nadja Akkad
Daniel Lunn
Lars Fugger
John Bell
Hansjörg Schild
Peter van Endert
Astrid K.N. Iversen
HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification
Cell Reports
author_facet Stefan Tenzer
Hayley Crawford
Phillip Pymm
Robert Gifford
Vattipally B. Sreenu
Mirjana Weimershaus
Tulio de Oliveira
Anne Burgevin
Jan Gerstoft
Nadja Akkad
Daniel Lunn
Lars Fugger
John Bell
Hansjörg Schild
Peter van Endert
Astrid K.N. Iversen
author_sort Stefan Tenzer
title HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification
title_short HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification
title_full HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification
title_fullStr HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification
title_full_unstemmed HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification
title_sort hiv-1 adaptation to antigen processing results in population-level immune evasion and affects subtype diversification
publisher Elsevier
series Cell Reports
issn 2211-1247
publishDate 2014-04-01
description Summary: The recent HIV-1 vaccine failures highlight the need to better understand virus-host interactions. One key question is why CD8+ T cell responses to two HIV-Gag regions are uniquely associated with delayed disease progression only in patients expressing a few rare HLA class I variants when these regions encode epitopes presented by ∼30 more common HLA variants. By combining epitope processing and computational analyses of the two HIV subtypes responsible for ∼60% of worldwide infections, we identified a hitherto unrecognized adaptation to the antigen-processing machinery through substitutions at subtype-specific motifs. Multiple HLA variants presenting epitopes situated next to a given subtype-specific motif drive selection at this subtype-specific position, and epitope abundances correlate inversely with the HLA frequency distribution in affected populations. This adaptation reflects the sum of intrapatient adaptations, is predictable, facilitates viral subtype diversification, and increases global HIV diversity. Because low epitope abundance is associated with infrequent and weak T cell responses, this most likely results in both population-level immune evasion and inadequate responses in most people vaccinated with natural HIV-1 sequence constructs. Our results suggest that artificial sequence modifications at subtype-specific positions in vitro could refocus and reverse the poor immunogenicity of HIV proteins. : CD8+ T cell responses against HIV-1 effectively delay disease progression in a minority of patients with relatively rare HLA variants but are ineffective in most. Here, Tenzer et al. identify fundamental HIV-1 adaptation to the conserved human antigen-processing machinery that feeds epitopes to HLA. This adaptation occurs at subtype-specific motifs, facilitates subtype diversification, is predictable, and results in CD8 epitope abundances that correlate inversely with the HLA allele frequencies in affected populations. Thus, HIV vaccine immunogenicity might be increased by unnatural substitutions at subtype-specific motifs.
url http://www.sciencedirect.com/science/article/pii/S2211124714002095
work_keys_str_mv AT stefantenzer hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT hayleycrawford hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT phillippymm hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT robertgifford hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT vattipallybsreenu hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT mirjanaweimershaus hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT tuliodeoliveira hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT anneburgevin hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT jangerstoft hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT nadjaakkad hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT daniellunn hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT larsfugger hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT johnbell hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT hansjorgschild hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT petervanendert hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
AT astridkniversen hiv1adaptationtoantigenprocessingresultsinpopulationlevelimmuneevasionandaffectssubtypediversification
_version_ 1724947072363266048
spelling doaj-70c00bdc9a134a478cc0c679e6af3abb2020-11-25T02:03:36ZengElsevierCell Reports2211-12472014-04-0172448463HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype DiversificationStefan Tenzer0Hayley Crawford1Phillip Pymm2Robert Gifford3Vattipally B. Sreenu4Mirjana Weimershaus5Tulio de Oliveira6Anne Burgevin7Jan Gerstoft8Nadja Akkad9Daniel Lunn10Lars Fugger11John Bell12Hansjörg Schild13Peter van Endert14Astrid K.N. Iversen15Institute of Immunology, University Medical Center of the Johannes-Gutenberg University of Mainz, Langenbeckstrasse 1, 55131 Mainz, GermanyMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UKMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UKAaron Diamond AIDS Research Center, 455 First Avenue, New York, NY 10016, USAMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UKInstitut National de la Santé et de la Recherche Médicale, Unité 1151, Centre National de la Recherche Scientifique, UMR8253, Université Paris Descartes, Sorbonne Paris Cité, Hôpital Necker, 149 rue de Sèvres, 75015 Paris, FranceAfrica Centre for Health and Population Studies, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, KwaZulu-Natal 3935, South Africa; Research Department of Infection, University College London, Cruciform Building, 90 Gower Street, London WC1E 6BT, UKInstitut National de la Santé et de la Recherche Médicale, Unité 1151, Centre National de la Recherche Scientifique, UMR8253, Université Paris Descartes, Sorbonne Paris Cité, Hôpital Necker, 149 rue de Sèvres, 75015 Paris, FranceDepartment of Infectious Diseases, Rigshospitalet, The National University Hospital, Blegdamsvej 9, 2100 Kbh Ø Copenhagen, DenmarkInstitute of Immunology, University Medical Center of the Johannes-Gutenberg University of Mainz, Langenbeckstrasse 1, 55131 Mainz, GermanyDepartment of Statistics, University of Oxford, 1 South Parks Road, Oxford OX1 3TG, UKMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UKOffice of the Regius Professor of Medicine, The Richard Doll Building, University of Oxford, Old Road Campus, Roosevelt Drive 1, Oxford OX3 7LF, UKInstitute of Immunology, University Medical Center of the Johannes-Gutenberg University of Mainz, Langenbeckstrasse 1, 55131 Mainz, GermanyInstitut National de la Santé et de la Recherche Médicale, Unité 1151, Centre National de la Recherche Scientifique, UMR8253, Université Paris Descartes, Sorbonne Paris Cité, Hôpital Necker, 149 rue de Sèvres, 75015 Paris, FranceMedical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Division of Clinical Neurology, Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Headley Way, Oxford OX3 9DS, UK; Corresponding authorSummary: The recent HIV-1 vaccine failures highlight the need to better understand virus-host interactions. One key question is why CD8+ T cell responses to two HIV-Gag regions are uniquely associated with delayed disease progression only in patients expressing a few rare HLA class I variants when these regions encode epitopes presented by ∼30 more common HLA variants. By combining epitope processing and computational analyses of the two HIV subtypes responsible for ∼60% of worldwide infections, we identified a hitherto unrecognized adaptation to the antigen-processing machinery through substitutions at subtype-specific motifs. Multiple HLA variants presenting epitopes situated next to a given subtype-specific motif drive selection at this subtype-specific position, and epitope abundances correlate inversely with the HLA frequency distribution in affected populations. This adaptation reflects the sum of intrapatient adaptations, is predictable, facilitates viral subtype diversification, and increases global HIV diversity. Because low epitope abundance is associated with infrequent and weak T cell responses, this most likely results in both population-level immune evasion and inadequate responses in most people vaccinated with natural HIV-1 sequence constructs. Our results suggest that artificial sequence modifications at subtype-specific positions in vitro could refocus and reverse the poor immunogenicity of HIV proteins. : CD8+ T cell responses against HIV-1 effectively delay disease progression in a minority of patients with relatively rare HLA variants but are ineffective in most. Here, Tenzer et al. identify fundamental HIV-1 adaptation to the conserved human antigen-processing machinery that feeds epitopes to HLA. This adaptation occurs at subtype-specific motifs, facilitates subtype diversification, is predictable, and results in CD8 epitope abundances that correlate inversely with the HLA allele frequencies in affected populations. Thus, HIV vaccine immunogenicity might be increased by unnatural substitutions at subtype-specific motifs.http://www.sciencedirect.com/science/article/pii/S2211124714002095